Protalix BioTherapeutics (PLX) Reports Q2 Loss of $0.16
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $1.17 +3.54%
Financial Fact:
GROSS PROFIT (LOSS): 422K
Today's EPS Names:
LCTC, IKT, LIFW, More
Financial Fact:
GROSS PROFIT (LOSS): 422K
Today's EPS Names:
LCTC, IKT, LIFW, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported Q2 EPS of ($0.16). Revenue for the quarter came in at $24.84 million versus the consensus estimate of $10.22 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Applied Materials reports upbeat guidance after Q2 results top estimates
- SWK Holdings (SWKH) Misses Q1 EPS by 37c
- Creative Media & Community Trust Corporation (CMCT) Misses Q1 EPS by 13c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
